Published in J Leukoc Biol on May 07, 2010
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol (2011) 2.94
Interaction between differentiating cell- and niche-derived signals in hematopoietic progenitor maintenance. Cell (2011) 2.31
A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes (2012) 1.13
An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics (2013) 1.11
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol (2014) 1.09
Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years. Semin Immunopathol (2015) 0.94
Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr (2014) 0.93
A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control study. J Thorac Dis (2015) 0.91
Expression of Drosophila adenosine deaminase in immune cells during inflammatory response. PLoS One (2011) 0.90
When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol (2014) 0.84
Immunological alterations mediated by adenosine during host-microbial interactions. Immunol Res (2011) 0.81
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol (2012) 0.81
MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes. Biomed Res Int (2015) 0.80
No association between serum adenosine deaminase activity and disease activity in Crohn's disease. Dig Dis Sci (2015) 0.80
Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. ScientificWorldJournal (2013) 0.79
Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J (2016) 0.78
Inborn errors of metabolism underlying primary immunodeficiencies. J Clin Immunol (2014) 0.77
Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression. Neuro Oncol (2017) 0.76
Mycobacterium tuberculosis ESAT6 and CPF10 Induce Adenosine Deaminase 2 mRNA Expression in Monocyte-Derived Macrophages. Tuberc Respir Dis (Seoul) (2016) 0.75
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment. Oncotarget (2016) 0.75
Early-onset stroke, polyarteritis nodosa (PAN), and livedo racemosa. J Am Acad Dermatol (2016) 0.75
A de novo atypical ring sSMC(22) characterized by array CGH in a boy with cat-eye syndrome. Mol Cytogenet (2014) 0.75
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders. Curr Rheumatol Rep (2017) 0.75
Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity (2006) 7.22
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity (2012) 3.30
Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med (2008) 3.03
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med (2006) 2.30
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci (2006) 2.29
Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods (2008) 2.10
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity (2002) 2.09
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med (2010) 2.07
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem (2003) 1.96
A dynamic map of antigen recognition by CD4 T cells at the site of Leishmania major infection. Cell Host Microbe (2009) 1.92
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem (2002) 1.88
Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity (2002) 1.78
Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. J Immunol (2008) 1.75
Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release. Cardiovasc Res (2006) 1.69
Circadian-related heteromerization of adrenergic and dopamine D₄ receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol (2012) 1.69
Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem (2004) 1.63
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci (2008) 1.52
Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci (2007) 1.48
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav (2007) 1.48
Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev (2003) 1.45
Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. J Exp Med (2007) 1.40
Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A (2010) 1.35
Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J Immunol (2006) 1.34
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A (2002) 1.30
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem (2008) 1.30
Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology (2007) 1.28
Cell biology and immunology of Leishmania. Immunol Rev (2011) 1.27
Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord (2004) 1.27
Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J Neurochem (2004) 1.27
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol (2009) 1.25
Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J Immunol (2003) 1.25
Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice. J Exp Med (2003) 1.24
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J Neurochem (2009) 1.23
Adenosine receptor heteromers and their integrative role in striatal function. ScientificWorldJournal (2007) 1.22
Role of electrostatic interaction in receptor-receptor heteromerization. J Mol Neurosci (2005) 1.22
Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique. FEBS Lett (2008) 1.20
Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists. PLoS One (2011) 1.20
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology (2008) 1.20
The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J Cell Biol (2007) 1.17
Aspects of the general biology of adenosine A2A signaling. Prog Neurobiol (2007) 1.17
Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol (2010) 1.17
Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol (2006) 1.16
CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med (2003) 1.15
Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J Biol Chem (2010) 1.15
Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology (2008) 1.15
Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Res Rev (2007) 1.14
Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem (2010) 1.14
Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers. J Med Chem (2009) 1.12
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci (2005) 1.12
Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem (2004) 1.12
Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo. PLoS Pathog (2011) 1.10
Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem (2005) 1.10
TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo. J Immunol (2005) 1.09
Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol Ther (2011) 1.09
Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. ScientificWorldJournal (2008) 1.08
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression. PLoS One (2010) 1.08
Adenosine-cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol (2010) 1.07
Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology (2008) 1.06
Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project. Haematologica (2009) 1.06
Visualizing early splenic memory CD8+ T cells reactivation against intracellular bacteria in the mouse. PLoS One (2010) 1.06
GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacol Ther (2009) 1.06
Role of glutamate on T-cell mediated immunity. J Neuroimmunol (2007) 1.05
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology (Berl) (2009) 1.05
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport. J Immunol (2003) 1.04
Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J Neurochem (2004) 1.04
Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Mol Pharmacol (2004) 1.03
The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J Biol Chem (2003) 1.03
Phosphodiesterases as therapeutic targets for Alzheimer's disease. ACS Chem Neurosci (2012) 1.03
Syk-dependent actin dynamics regulate endocytic trafficking and processing of antigens internalized through the B-cell receptor. Mol Biol Cell (2007) 1.02
Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem (2010) 1.02
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. J Biol Chem (2009) 1.02
Tracking N-acetyllactosamine on cell-surface glycans in vivo. Angew Chem Int Ed Engl (2011) 1.01
Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination. Epilepsia (2007) 1.00
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J Psychopharmacol (2010) 1.00
Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors. Eur Heart J (2010) 1.00
Cytosolic expression of SecA2 is a prerequisite for long-term protective immunity. Cell Microbiol (2007) 0.98
Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. PLoS One (2013) 0.97
Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem (2004) 0.97
Short-term effect of miglustat in every day clinical use in treatment-naïve or previously treated patients with type 1 Gaucher's disease. Haematologica (2006) 0.97
Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine. Brain Res (2006) 0.97
Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. Pharmacol Ther (2007) 0.97
Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J Biol Chem (2012) 0.96
New methods to evaluate colocalization of fluorophores in immunocytochemical preparations as exemplified by a study on A2A and D2 receptors in Chinese hamster ovary cells. J Histochem Cytochem (2005) 0.96
Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice. J Alzheimers Dis (2012) 0.95
Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. Neuropsychopharmacology (2006) 0.95
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology (2013) 0.95
Oligomerization of G-protein-coupled receptors: a reality. Curr Opin Pharmacol (2009) 0.95
A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol (2003) 0.94
Plasma membrane diffusion of G protein-coupled receptor oligomers. Biochim Biophys Acta (2008) 0.94
Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function. Front Neuroanat (2011) 0.93
Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization. Bioessays (2008) 0.93
Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells. J Leukoc Biol (2010) 0.92
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Addict Biol (2010) 0.92
Crystal structure of enterotoxigenic Escherichia coli colonization factor CS6 reveals a novel type of functional assembly. Mol Microbiol (2012) 0.91
Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. J Neurosci (2011) 0.91